Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 242 results for "mirati"

Photos: President Pranab Mukherjee relaxes with family in his ancestral village
First Post.com

View: Will Pranab Mukherjee's book drop a bomb?

Poltu was born to a poor Brahmin family in a village called Mirati, 1935, in Birbhum district of West Bengal. His father, a schoolmaster, was frequently in and out of jail as he served the greater cause of Indian freedom from British colonialism. Economic Times, 2 weeks ago

6 images for mirati

KXXV-TV, 5 days ago
Sys-Con Media, 1 month ago
Emirates247, 1 month ago
Securities Technology Monitor, 1 month ago
ABC News 4 Charleston, 1 month ago
First Post.com, 2 months ago

Mirati Therapeutics Reports Third Quarter 2014 Financial Results and Provides Business Update

SAN DIEGO, Nov. 10, 2014 /PRNewswire/ --Mirati Therapeutics, Inc. ("Mirati") ( MRTX ) today reported financial results for the third quarter ended September 30, 2014 and provided an update on its drug development programs. "We are excited to ...
 Yahoo! Finance1 month ago Mirati Therapeutics Reports Third Quarter 2014 Financial Results And Provides Business Update  BioSpace1 month ago
[x]  

Mirati begins dosage in MGCD265 Phase 1b clinical trial for NSCLC

Mirati Therapeutics, Inc. (NASDAQ: MRTX) today announced that the first patient with Non-Small Cell Lung Cancer (NSCLC) has been dosed in a Phase 1b clinical trial of MGCD265 in selected patients exhibiting genetic alterations of MET or Axl. In this ...
 News-Medical.Net5 days ago Mirati Therapeutics Doses First Patient in Expansion Cohorts of Phase 1b Trial of MGCD265 in Genetically Selected Patients  Barchart5 days ago Mirati Therapeutics Doses First Patient In Expansion Cohorts Of Phase 1b Trial Of MGCD265 In Genetically Selected Patients  BioSpace5 days ago Mirati Therapeutics (MRTX) Doses First Patient In Expansion Cohorts Of Phase 1b Trial Of MGCD265 In Genetically Selected Patients 12/23/2014  ClinicSpace5 days ago
[x]  

Mirati beats 3Q profit forecasts

The San Diego-based company said it had a loss of 72 cents per share. The results surpassed Wall Street expectations. The average estimate of analysts surveyed by Zacks Investment Research was for a
 Yahoo! UK and Ireland1 month ago

MIRATI THERAPEUTICS, INC. FILES (8-K) Disclosing Change in Directors or Principal Officers, Financial Statements and Exhibits

(Edgar Glimpses Via Acquire Media NewsEdge) Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (b) On November 5, 2014, the Board of ...
 TMC Net1 month ago

MIRATI Cosmetics Launch

Unfortunately we are unable to process your request at this time. This error is usually temporary. Please try again later. If you continue to experience this error, it may be caused by one of the following: You may want to scan your system ...
 Yahoo! Finance2 months ago

Mirati Therapeutics Price Target Raised to $37.00

Filed Under: Analysts Price Targets • Market News Research analysts at Piper Jaffray raised their price target on shares of Mirati Therapeutics (NASDAQ:MRTX) from $31.00 to $37.00 in a report released on Monday. The firm currently has an ...
 American Banking News5 days ago

Mirati Therapeutics Inc (MRTX) Jumps 6.2% on December 16

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and ...
 Equities.com1 week ago Mirati Therapeutics Inc (MRTX) Hits New 52-week Low During December 01 Session  Equities.com3 weeks ago

Oversold Conditions For Mirati Therapeutics (MRTX)

at 13:20 PM EST Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called ...
 Fat Pitch Financials3 weeks ago
[x]  

Mirati Therapeutics (MRTX) Announces Quarterly Earnings Results, Beats Expectations By $0.12 EPS

Mirati Therapeutics (NASDAQ:MRTX) issued its quarterly earnings data on Monday. The company reported ($0.64) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.76) by $0.12, American Banking News reports. On a related ...
 SleekMoney1 month ago Mirati Therapeutics (MRTX) Posts Q3 Loss of 64c/Share  Town Hall1 month ago Mirati Therapeutics (MRTX) Posts Quarterly Earnings Results, Beats Estimates By $0.12 EPS  WKRB News1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less